RMH Holdings Limited (8437) AI Stock Analysis

• Market Cap: HK$9.46M
• Dividend Yield: N/A
• Average Volume (3M): 2.84K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.96
• Revenue Growth: 14.64%
• EPS Growth: -81.95%
• Country: HK
• Employees: 45
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): -0.03
• Shares Outstanding: 66,600,000
• 10 Day Avg. Volume: 4,880
• 30 Day Avg. Volume: 2,840
• PEG Ratio: >-0.01
• Price to Book (P/B): -0.15
• Price to Sales (P/S): 0.59
• P/FCF Ratio: 26.41
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 1

• Rating: 40 Underperform
• Price Target: HK$0.00 ▼(-100.00% Downside)

The overall stock score is heavily influenced by the company's poor financial performance, characterized by declining revenues, persistent losses, and financial instability. Technical analysis indicates a bearish trend, with the stock being oversold. Valuation metrics are unfavorable, with a negative P/E ratio and no dividend yield, further impacting the stock's attractiveness.

RMH Holdings Limited Business Overview & Revenue Model

Company Description

RMH Holdings Limited (8437) is a Singapore-based investment holding company primarily engaged in the provision of medical and aesthetic healthcare services. The company operates through its subsidiaries, offering a wide range of aesthetic medical services including dermatology treatments, aesthetic surgeries, and skin care products. RMH Holdings is known for its cutting-edge technology and experienced medical professionals, providing clients with high-quality and personalized care.

How the Company Makes Money

RMH Holdings Limited generates revenue mainly through its aesthetic medical services. The company charges clients for various cosmetic and dermatological procedures, which include non-invasive treatments, surgical procedures, and skin care consultations. Additionally, RMH Holdings earns income from the sale of specialized skin care products tailored to enhance the results of its aesthetic treatments. The company may also benefit from strategic partnerships with technology providers and cosmetic suppliers that aid in expanding its service offerings and enhancing operational efficiency.

RMH Holdings Limited Financial Statement Overview

Summary

RMH Holdings Limited is facing significant financial challenges. The income statement reflects declining revenues and persistent losses, the balance sheet shows financial instability with negative equity, and cash flows have improved but remain insufficient. Strategic financial restructuring and operational improvements are crucial for recovery.

Income Statement

RMH Holdings Limited shows a consistent decline in revenue from 2019 to 2024, with significant negative EBIT and net income in recent years. The gross profit margin is positive, but net profit margins are severely negative, indicating operational inefficiencies and high costs. Revenue growth remains negative, reflecting challenges in maintaining sales momentum.

Balance Sheet

The balance sheet reflects a concerning financial structure with negative stockholders' equity and high total liabilities exceeding assets, indicating potential insolvency risks. The debt-to-equity ratio is non-meaningful due to negative equity, emphasizing financial instability. The equity ratio is negative, further highlighting balance sheet weaknesses.

Cash Flow

Operating cash flow has improved slightly but remains low relative to net income, indicating cash flow issues. Free cash flow has shown improvements, but the free cash flow to net income ratio remains weak. Despite minor improvements, cash flow generation is inadequate to cover financing needs.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.22M	5.04M	3.18M	4.24M	238.00K	7.81M
Gross Profit	-1.01M	3.15M	1.54M	707.00K	-2.05M	5.12M
EBITDA	-3.85M	-2.60M	-5.00M	-7.84M	-2.59M	-6.47M
Net Income	-5.06M	-3.51M	-6.75M	-18.65M	-8.79M	-9.27M
Balance Sheet
Total Assets	4.92M	3.97M	4.15M	12.40M	18.91M	20.49M
Cash, Cash Equivalents and Short-Term Investments	557.00K	566.00K	306.00K	2.12M	2.75M	4.93M
Total Debt	4.10M	4.28M	258.00K	2.86M	11.06M	11.76M
Total Liabilities	29.12M	28.38M	16.67M	18.69M	14.34M	14.96M
Stockholders Equity	-19.27M	-19.50M	-12.41M	-6.29M	4.57M	5.53M
Cash Flow
Free Cash Flow	-8.51M	113.00K	368.00K	-6.41M	-7.33M	-6.64M
Operating Cash Flow	-8.50M	114.00K	781.00K	-5.09M	-6.13M	-4.51M
Investing Cash Flow	6.61M	142.00K	1.52M	-3.28M	-506.00K	-6.69M
Financing Cash Flow	1.06M	-4.00K	-2.46M	6.65M	3.82M	3.47M

RMH Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.14
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8437, the sentiment is Negative. The current price of 0.14 is below the 20-day moving average (MA) of 0.15, below the 50-day MA of 0.15, and below the 200-day MA of 0.17, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 14.52 is Positive, neither overbought nor oversold. The STOCH value of 13.25 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8437.

RMH Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2293	75 Outperform	HK$213.30M	12.10	7.84%	4.72%	-21.50%	-43.12%
8161	56 Neutral	HK$24.96M	3.10	105.83%	―	-8.48%	―
8357	55 Neutral	HK$94.85M	―	-10.31%	―	-11.68%	-71.01%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
8143	51 Neutral	HK$198.40M	―	-18.22%	―	-58.63%	40.85%
8307	48 Neutral	HK$53.56M	―	-44.60%	―	-8.20%	-10.39%
8437	40 Underperform	HK$9.46M	―	―	―	14.64%	-81.95%